SPP1 and cancer: In previous studies, osteopontin (SPP1) was investigated in the urine of nephrolithiasis [101], Alzheimer’s disease patients [102], and in cancer patients presenting cisplatin-induced nephrotoxicity [103], and was found to provide diagnostic value.